
Rejoy7.5 mg
Eskayef Bangladesh Ltd.
Mirtazapine is an atypical antidepressant with the following evidence-based uses: Established / FDA-approved use Major Depressive Disorder (MDD) in adults — Mirtazapine is indicated for the…
Mirtazapine is an atypical antidepressant with the following evidence-based uses:
Use of Mirtazapine for any indication should be individualized and supervised by a physician.
Dosage of Mirtazapine should be individualized under medical supervision based on response and tolerability.
| Indication | Population | Typical Dosage |
|---|---|---|
| Major Depressive Disorder | Adults | Initiate at 15 mg once daily, preferably in the evening before sleep. May be increased at intervals of 1–2 weeks up to a usual maximum of 45 mg/day, based on response and tolerability. |
| Major Depressive Disorder | Elderly patients | Use the lower end of the dosing range; titrate cautiously due to reduced clearance and increased sensitivity to side effects. |
| Major Depressive Disorder | Hepatic or renal impairment | Clearance is reduced; start at a lower dose and titrate slowly with close monitoring. |
| Any indication | Children/adolescents (<18 years) | Not approved; safety and efficacy have not been established (see Pediatric Uses). |
Do not stop Mirtazapine abruptly after prolonged use; discontinuation should be gradual and supervised by a physician to reduce the risk of discontinuation symptoms.
The most commonly reported side effects of Mirtazapine include:
Mirtazapine is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.